Anti-RTBDN functional antibody

Anti-RTBDN functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to RTBDN/RTBDN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0453-Ab-1/ GM-Tg-hg-SE0453-Ab-2Anti-Human RTBDN monoclonal antibodyHuman
GM-Tg-rg-SE0453-Ab-1/ GM-Tg-rg-SE0453-Ab-2Anti-Rat RTBDN monoclonal antibodyRat
GM-Tg-mg-SE0453-Ab-1/ GM-Tg-mg-SE0453-Ab-2Anti-Mouse RTBDN monoclonal antibodyMouse
GM-Tg-cynog-SE0453-Ab-1/ GM-Tg-cynog-SE0453-Ab-2Anti-Cynomolgus/ Rhesus macaque RTBDN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0453-Ab-1/ GM-Tg-felg-SE0453-Ab-2Anti-Feline RTBDN monoclonal antibodyFeline
GM-Tg-cang-SE0453-Ab-1/ GM-Tg-cang-SE0453-Ab-2Anti-Canine RTBDN monoclonal antibodyCanine
GM-Tg-bovg-SE0453-Ab-1/ GM-Tg-bovg-SE0453-Ab-2Anti-Bovine RTBDN monoclonal antibodyBovine
GM-Tg-equg-SE0453-Ab-1/ GM-Tg-equg-SE0453-Ab-2Anti-Equine RTBDN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0453-Ab-1/ GM-Tg-hg-SE0453-Ab-2; GM-Tg-rg-SE0453-Ab-1/ GM-Tg-rg-SE0453-Ab-2;
GM-Tg-mg-SE0453-Ab-1/ GM-Tg-mg-SE0453-Ab-2; GM-Tg-cynog-SE0453-Ab-1/ GM-Tg-cynog-SE0453-Ab-2;
GM-Tg-felg-SE0453-Ab-1/ GM-Tg-felg-SE0453-Ab-2; GM-Tg-cang-SE0453-Ab-1/ GM-Tg-cang-SE0453-Ab-2;
GM-Tg-bovg-SE0453-Ab-1/ GM-Tg-bovg-SE0453-Ab-2; GM-Tg-equg-SE0453-Ab-1/ GM-Tg-equg-SE0453-Ab-2
Products NameAnti-RTBDN monoclonal antibody
Formatmab
Target NameRTBDN
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RTBDN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0453-Ag-1Recombinant multi-species RTBDN protein


    Target information

    Target IDGM-SE0453
    Target NameRTBDN
    Gene ID83546,234542,304667,716766,476698,101086375,784508,100064212
    Gene Symbol and SynonymsA330096I21Rik,RTBDN,Rtbnd
    Uniprot AccessionQ9BSG5,Q4TUC0
    Uniprot Entry NameRTBDN_HUMAN,RTBDN_CANLF
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132026
    Target ClassificationN/A

    The target: RTBDN, gene name: RTBDN, also named as . This gene was first identified in a study of human eye tissues. The protein encoded by this gene is preferentially expressed in the retina and may play a role in binding retinoids and other carotenoids as it shares homology with riboflavin binding proteins. Alternative splicing results in multiple transcript variants and protein isoforms. [provided by RefSeq, Jul 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.